This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Reneo Pharmaceuticals, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Alejandro Dorenbaum - Innovator in Pharmaceutical Treatments
Introduction
Alejandro Dorenbaum is a prominent inventor based in San Diego, CA (US), known for his contributions to the field of pharmaceuticals. With a focus on innovative treatments, he has made significant strides in the development of therapeutic compounds.
Latest Patents
Dorenbaum holds a patent for the "Use of PPAR-delta agonists in the treatment of disease." This patent describes the use of sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate in the preparation of pharmaceutical compositions aimed at treating diseases or conditions that benefit from the administration of a PPARδ agonist compound.
Career Highlights
Throughout his career, Dorenbaum has been associated with Reneo Pharmaceuticals, Inc., where he has played a crucial role in advancing pharmaceutical research and development. His work has contributed to the understanding and treatment of various medical conditions.
Collaborations
Dorenbaum has collaborated with notable colleagues, including Niall O′Donnell and Lynn Purkins, enhancing the innovative efforts within his team and contributing to the success of their projects.
Conclusion
Alejandro Dorenbaum's work exemplifies the impact of
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile